BAJAJ BROKING
Torrent Pharmaceuticals will acquire three anti-diabetes brands from Boehringer Ingelheim by March 2025. The ₹19,912 crore diabetes medication market grows at 7.7% CAGR, supporting Torrent Pharmaceuticals share price optimism.
Torrent Pharmaceuticals Ltd has entered into an agreement to acquire three anti-diabetes brands—Cospiaq, Cospiaq Met, and Xilingio—from Boehringer Ingelheim International GmbH. These brands, which feature empagliflozin as a key ingredient, are used in glycemic control for type 2 diabetes mellitus patients. Torrent has been co-marketing these brands since 2022. The acquisition, expected to close by March 2025, will further strengthen the company's diabetes care portfolio in India.
Also read: Bharat Forge Launches QIP, Sets Floor Price At ₹1,323.54 Per Share
Brands Acquired: Cospiaq, Cospiaq Met, and Xilingio.
Completion Timeline: March 2025.
Key Ingredient: Empagliflozin, an SGLT-2 inhibitor.
Indian Diabetes Market: Valued at ₹19,912 crore, growing at 7.7% CAGR.
Torrent Pharmaceuticals Share Price Impact: Positive momentum expected.
Also read: Bondada Engineering Secures ₹108.9 Crore Order From BREDA
India has the second-largest population of diabetes patients, with an estimated 74.2 million adults as of 2021, projected to rise to 125 million by 2045. The market for SGLT-2 inhibitors, such as empagliflozin, is valued at ₹3,235 crore and is expanding rapidly at a CAGR of 25%, outpacing the overall diabetes market growth.
Details | Figures |
Diabetes Patient Base (2021) | 74.2 million |
Estimated Patients (2045) | 125 million |
Indian Diabetes Medication Market | ₹19,912 crore |
SGLT-2 Inhibitors Market | ₹3,235 crore |
SGLT-2 Inhibitors Growth Rate (CAGR) | 25% |
Torrent’s acquisition is a strategic move to deepen its presence in the ₹19,912 crore Indian diabetes medication market. With the demand for effective diabetes management solutions growing, the acquisition of these brands enhances Torrent’s ability to cater to this expanding segment while bolstering its position in the oral anti-diabetic space.
This development is expected to generate positive investor sentiment, supporting Torrent Pharmaceuticals share price. The deal highlights the company’s focus on growth within high-potential therapeutic areas, particularly in the rapidly expanding diabetes segment.
Torrent Pharmaceuticals’ acquisition of anti-diabetes brands from Boehringer Ingelheim reinforces its leadership in the diabetes care market. With robust market growth and increasing patient needs, the move is expected to strengthen the company's portfolio and favourably influence Torrent Pharmaceuticals share price.
Also read: Vodafone Idea Board to Meet on Dec 9 to Discuss ₹2,000 Crore Fundraising
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Standard Deviation: Meaning, How To Use and Calculate
14 Dec, 2024 | 5 Min. read
Business Forecasting: Definition, Methods, and Models
14 Dec, 2024 | 8 Min. read
Modern Portfolio Theory (MPT): Definition, Types & How To Use
14 Dec, 2024 | 8 Min. read
ASM & GSM Meaning - List of ASM & GSM Stocks
14 Dec, 2024 | 7 Min. read
What Is Nifty BeES? A Guide to Its Benefits and Working
14 Dec, 2024 | 6 Min. read
Nifty Healthcare Index
14 Dec, 2024 | 1 Min. read
Hedging: Meaning, Types, Risks and Strategie
14 Dec, 2024 | 6 Min. read
Bollinger Bands: Meaning, How To Interpret and Use
14 Dec, 2024 | 7 Min. read
Moving Averages Indicator: Variations & Examples
13 Dec, 2024 | 4 Min. read
Learn Everything About Breakout Trading
13 Dec, 2024 | 9 Min. read
Gold Price in India | Gold Drops 1% After Reaching Five-Week High
13 Dec, 2024 | 39 Min. read
Statement of Account and Demat Account: Meaning & Differences
13 Dec, 2024 | 4 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading